Open access · CC-BY
via OpenAlex
Metabolic reprogramming: a bridge between aging and tumorigenesis
Stanislav Drápela, Didem Ilter, Ana P. Gomes
Molecular Oncology · 2022 · ▲ 41 citations
Abstract
Aging is the most robust risk factor for cancer development, with more than 60% of cancers occurring in those aged 60 and above. However, how aging and tumorigenesis are intertwined is poorly understood and a matter of significant debate. Metabolic changes are hallmarks of both aging and tumorigenesis. The deleterious consequences of aging include dysfunctional cellular processes, the build-up of metabolic byproducts and waste molecules in circulation and within tissues, and stiffer connective tissues that impede blood flow and oxygenation. Collectively, these age-driven changes lead to metabolic reprogramming in different cell types of a given tissue that significantly affects their cellular functions. Here, we put forward the idea that metabolic changes that happen during aging help create a favorable environment for tumorigenesis. We review parallels in metabolic changes that happen during aging and how these changes function both as adaptive mechanisms that enable the development of malignant phenotypes in a cell-autonomous manner and as mechanisms that suppress immune surveillance, collectively creating the perfect environment for cancers to thrive. Hence, antiaging therapeutic strategies that target the metabolic reprogramming that occurs as we age might provide new opportunities to prevent cancer initiation and/or improve responses to standard-of-care anticancer therapies.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1002/1878-0261.13261
- Canonical
- link ↗
- Fetched
- 2026-09-29 MST
Cite this
APA
Drápela, S., Ilter, D., & Gomes, A.P. (2022). Metabolic reprogramming: a bridge between aging and tumorigenesis. <em>Molecular Oncology</em>. https://doi.org/10.1002/1878-0261.13261
Vancouver
Drápela S, Ilter D, Gomes AP. Metabolic reprogramming: a bridge between aging and tumorigenesis. Molecular Oncology. 2022. doi:10.1002/1878-0261.13261.
BibTeX
@article{stanislav2022Metabo,
title = {Metabolic reprogramming: a bridge between aging and tumorigenesis},
author = {Stanislav Drápela and Didem Ilter and Ana P. Gomes},
journal = {Molecular Oncology},
year = {2022},
doi = {10.1002/1878-0261.13261},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Ageing and Cancer Research & Treatment 2024
Open access · CC-BY
Protein post-translational modifications in aging and cancer: Mechanisms and translational implications
Aging and Disease 2025
Open access · CC-BY
Aging-Related Mechanisms Underlying Carcinogenesis: Therapeutic Opportunities
Aging and disease 2025
Open access · OA
Unveiling the Relation between Cellular Aging, Epigenetics and Cancer.
Aging and Disease 2025
Open access · CC-BY
Unveiling the Relation between Cellular Ageing, Epigenetics and Cancer
Oxidative Medicine and Cellular Longevity 2016
Open access · CC-BY
Sirtuins and Cancer: Role in the Epithelial‐Mesenchymal Transition
Cell 2007
Open access · OA